Detalles de la búsqueda
1.
Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter.
Nat Struct Mol Biol
; 31(1): 159-169, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057552
2.
A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.
Biochem Biophys Res Commun
; 434(2): 191-6, 2013 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-23501107
3.
Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.
Bioorg Med Chem
; 20(16): 5033-41, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22824762
4.
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Bioorg Med Chem
; 20(19): 5705-19, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22959556
5.
Machine learning to estimate the local quality of protein crystal structures.
Sci Rep
; 11(1): 23599, 2021 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34880321
Resultados
1 -
5
de 5
1
Próxima >
>>